Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

BIOBIO
Showing 8 of 30 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in BIO RAD LABS INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 426,038 shares of BIO (BIO RAD LABS INC), worth $118.8M as of 2026-Q1. The position was increased (+7.8% shares). BIO represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$118.8M

Current Shares

426,038

Total Value Change

-$546,734

Total Shares Change

-10,800

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
426,038
+7.8%
$118.8M0.0%$280.19
33
2025-Q4
Decreased
395,077
-0.5%
$119.7M0.0%$304.51
0
2025-Q3
Increased
397,171
+2271.3%
$111.4M0.0%$270.11
48
2025-Q2
Decreased
16,749
-95.6%
$4M0.0%$243.98
0
2025-Q1
Decreased
382,807
-1.5%
$93.2M0.0%$243.00
0
2024-Q4
Decreased
388,627
-11.9%
$127.7M0.0%$326.34
0
2024-Q3
Increased
441,098
+1.0%
$147.6M0.0%$331.77
30
2024-Q2
Increased
436,838
+3.5%
$119.3M0.0%$273.11
31

Other major holders of BIO: First Eagle Investment Management, LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used